NDRG2诱导miR-630促进宫颈癌细胞辐射抗性的作用与机制

基本信息
批准号:81272490
项目类别:面上项目
资助金额:70.00
负责人:刘军叶
学科分类:
依托单位:中国人民解放军第四军医大学
批准年份:2012
结题年份:2016
起止时间:2013-01-01 - 2016-12-31
项目状态: 已结题
项目参与者:李燕,周咏春,金成,吴琳,刘学武,郭娟,安广州,李瑾慧
关键词:
辐射敏感性宫颈癌NDRG2miR630
结项摘要

The mechanisms underlying radioresistance of cervical cancer remain to be elucidated. Our study supported by a grant from National Natural Science Foundation of China revealed that hypoxia and radiation induced NDRG2 expression in human cervical cancer cells in a HIF-1-dependent manner and that NDRG2 promoted radioresistance of cervical cancer cells through inhibiting radiation-induced apoptosis. We further demonstrated that miR-630 was up-regulated in NDRG2-overexpressed cells and radioresistant cervical cancer cells, miR-630 mimics promoted radioresistance while its inhibitor enhanced radiosensitivity of cervical cancer cells, and that NDRG2 promoted radiation-induced up-regulation of miR-630. Based on these data, we hypothesized that NDRG2 induced miR-630 expression and miR-630 in turn promoted radioresistance of cervical cancer cells. In the current study, reporter gene assay, EMSA and Chip assay will be employed to uncover how NDRG2 induced miR-630 expression. RIP-chip and iTRAQ will be used to identify miR-630 targets. miR-630 and its targets will be modulated in cervical cancer cells by infection or transfection of expressing vectors or antagomirs. Then the influence of miR-630 and its targets on radiosensitivity and DNA damage signal transduction will be explored. The study will deepen our understanding of tumor radioresistance and help us to find novel therapeutic targets for radio-sensitizing reagents.

宫颈癌辐射抗性的机制仍未完全阐明。申请者前一个已结题的国科金研究表明,乏氧和辐射通过HIF-1诱导NDRG2在宫颈癌细胞的表达,NDRG2通过抑制辐射诱导的凋亡而增强癌细胞的辐射抗性。进一步研究发现,miR-630在NDRG2过表达细胞及辐射抗性细胞中表达上调,其模拟物促进辐射抗性而抑制剂增强辐射敏感性,NDRG2促进辐射对miR-630的表达诱导作用。我们据此提出了NDRG2诱导miR-630促进宫颈癌细胞辐射抗性的理论假设。本项目将借助报告基因实验、EMSA、Chip明确NDRG2促进miR-630表达的机制,联用RIP-chip和iTRAQ技术寻找miR-630的靶分子,通过基因转染和体内外实验阐明miR-630及其靶分子对辐射敏感性的调控作用,明确它们对辐射诱导的DNA损伤信号通路的影响。研究结果有助于加深对肿瘤辐射抗性机制的理解,为寻找新的具有辐射增敏作用的治疗靶点提供理论依据。

项目摘要

我们前期研究发现miR-630 在 NDRG2 过表达细胞及辐射抗性细胞中表达上调。本课题旨在探讨辐射诱导 miR-630 促进宫颈癌细胞辐射抗性的作用及分子机制。.取得的研究结果有:1.辐射可诱导宫颈癌Hela细胞中miR-630表达上调,并具有剂量和时间依赖性;2. miR-630可增强辐射后宫颈癌Hela细胞的活性及克隆形成能力; 3. miR-630降低细胞的自发凋亡及辐射诱导的细胞凋亡,miR-630亦可增强抗凋亡蛋白Bcl-2表达,同时抑制促凋亡蛋白Bax, Caspase 3, Caspase 7 and Caspase 9表达;4. miR-630可增强宫颈癌Hela细胞的致瘤性;5. miR-630可增强Hela细胞侵袭转移能力,同时通过降低上皮标志物E-cadherin和Cytokeratin的表达、升高间质标志物N-cadherin的表达来诱导上皮间质转化(EMT)的发生。.在完成本课题研究内容的同时,我们在课题实施中还发现乏氧也可以快速诱导Hela细胞中miR-630表达上调,并长时间维持miR-630的高表达水平。.目前课题取得的初步结论是:辐射和乏氧可诱导miR-630在宫颈癌Hela细胞中表达。miR-630可通过抑制辐照诱导的细胞凋亡增强宫颈癌Hela细胞的辐射抗性。miR-630可诱导宫颈癌Hela细胞发生EMT从而促进Hela细胞的侵袭转移。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway

MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway

DOI:10.1002/cam4.1029.
发表时间:2017
2

Inhibiting miR-22 Alleviates Cardiac Dysfunction by Regulating Sirt1 in Septic Cardiomyopathy

Inhibiting miR-22 Alleviates Cardiac Dysfunction by Regulating Sirt1 in Septic Cardiomyopathy

DOI:10.3389/fcell.2021.650666
发表时间:2021
3

C-藻蓝蛋白抑制TGF-β1诱导的宫颈癌Caski细胞上皮-间充质转化

C-藻蓝蛋白抑制TGF-β1诱导的宫颈癌Caski细胞上皮-间充质转化

DOI:10.3872/j.issn.1007-385x.2020.02.005
发表时间:2020
4

MiR-516a-5p inhibits the proliferation of non-small cell lung cancer by targeting HIST3H2A

MiR-516a-5p inhibits the proliferation of non-small cell lung cancer by targeting HIST3H2A

DOI:10.1177/2058738419841481
发表时间:2019
5

Inhibition of miR-193a-3p protects human umbilical vein endothelial cells against intermittent hypoxia-induced endothelial injury by targeting FAIM2

Inhibition of miR-193a-3p protects human umbilical vein endothelial cells against intermittent hypoxia-induced endothelial injury by targeting FAIM2

DOI:
发表时间:2020

相似国自然基金

1

NDRG2对宫颈癌细胞辐射敏感性的调节作用及分子机制

批准号:30600161
批准年份:2006
负责人:刘军叶
学科分类:H1821
资助金额:23.00
项目类别:青年科学基金项目
2

辐射/乏氧诱导的HIF-1-miR-1290-GSK-3β促进宫颈癌细胞侵袭和转移的研究

批准号:31470828
批准年份:2014
负责人:刘军叶
学科分类:C0503
资助金额:85.00
项目类别:面上项目
3

环状RNA circ_0001589促进宫颈癌细胞生长的作用与机制研究

批准号:81772765
批准年份:2017
负责人:郑英如
学科分类:H1805
资助金额:53.00
项目类别:面上项目
4

电离辐射诱导CSCs生成在肺腺癌辐射抗性中的作用及其调控机制研究

批准号:31570854
批准年份:2015
负责人:李峰生
学科分类:C0503
资助金额:65.00
项目类别:面上项目